Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Pfizer”

A 2-Year Phase 3 Study Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background MethotrexateCompleted
NCT00847613Phase 3Updated May 16, 2024
Sponsor: Pfizer
Arthritis, Rheumatoid
United States, Australia, Brazil, Bulgaria, Canada +10 more
Impact of Rheumatoid Arthritis on Body Composition, Bone Marrow Adiposity and Bone Mineral Density: a Case-control StudyTerminated
NCT05269069N/AUpdated May 16, 2024
Sponsor: University Hospital, Lille
Rheumatoid Arthritis
France
Retrospective Study Collecting Neurological Follow-up of Hereditary Transthyretin Amyloidosis (ATTRv) Patients Included in B3461028 and B3461045.Completed
NCT05560555N/AUpdated May 13, 2024
Sponsor: Pfizer
Hereditary Transthyretin Amyloidosis (ATTRv) · Polyneuropathy
Spain
STUDY OF PF-06882961 IN PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS WITH VARYING DEGREES OF RENAL IMPAIRMENT AND PARTICIPANTS WITHOUT RENAL IMPAIRMENTCompleted
NCT04616027Phase 1Updated May 10, 2024
Sponsor: Pfizer
Diabetes Mellitus, Type 2 · Renal Impairment · Healthy
United States
Relative Bioavailability Study of Nirmatrelvir/Ritonavir Oral Powder Relative to the Commercial Tablets and Estimation of the Effect of Food on Bioavailability of the Nirmatrelvir/Ritonavir Oral Powder in Healthy Participants.Completed
NCT05544786Phase 1Updated May 10, 2024
Sponsor: Pfizer
Biological Availability
Belgium
Real-world Clinical Patterns Of Care And Outcomes Among AfME mRCC Patients Receiving Sunitinib as First Line Therapy.Terminated
NCT03140176N/AUpdated May 10, 2024
Sponsor: Pfizer
Metastatic Renal Cell Carcinoma
Algeria, Egypt, Kuwait, Morocco
A Trial of PF-07901800 (TTI-621) for Patients With Hematologic Malignancies and Selected Solid TumorsTerminated
NCT02663518Phase 1Updated May 10, 2024
Sponsor: Pfizer
Hematologic Malignancies · Solid Tumor
United States, Canada
A Study to Assess the Safety and Efficacy of Oral Etrasimod in Adult Participants With Eosinophilic EsophagitisCompleted
NCT04682639Phase 2Updated May 6, 2024
Sponsor: Pfizer
Eosinophilic Esophagitis
United States, Australia, Belgium, Canada, Germany +3 more
Safety and Efficacy Trial of Zavegepant* Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental OxygenTerminated
NCT04346615Phase 2, Phase 3Updated May 2, 2024
Sponsor: Pfizer
COVID-19 Infection
United States
Voxelotor Neurocognitive Function StudyTerminated
NCT05228834Phase 3Updated May 2, 2024
Sponsor: Pfizer
Sickle Cell Disease
United States
A Study to Describe the Safety of a Vaccine (Called 13vPnC) in Healthy People 18 to 49 Years of Age in IndiaCompleted
NCT05329259Phase 4Updated Apr 26, 2024
Sponsor: Pfizer
Pneumococcal Disease
India
TACE Plus Axitinib and Hydroxychlorquine for Liver-Dominant Metastatic Colorectal Cancer (CRC)Terminated
NCT04873895Phase 1Updated Apr 26, 2024
Sponsor: Abramson Cancer Center at Penn Medicine
Colorectal Neoplasms Malignant
United States
The African-PREDICT StudyActive Not Recruiting
NCT03292094N/AUpdated Apr 25, 2024
Sponsor: North-West University, South Africa
Cardiovascular Diseases · Hypertension · Health Risk Behaviors · Arterial Stiffness
South Africa
A Study Of PF-04449913 In Select Hematologic MalignanciesCompleted
NCT00953758Phase 1Updated Apr 25, 2024
Sponsor: Pfizer
Hematologic Malignancies
United States, Italy
A Study to Learn About the Effect of Avelumab First-Line Maintenance in Canadian People With Advanced Bladder CancerTerminated
NCT05699135N/AUpdated Apr 24, 2024
Sponsor: Pfizer
Urinary Bladder Neoplasms · Bladder Cancer · Bladder Tumors · Urothelial Carcinoma
Canada
A Study to Learn About the Drug-drug Interactions of Sisunatovir in Healthy Adult ParticipantsCompleted
NCT03782662Phase 1Updated Apr 22, 2024
Sponsor: Pfizer
Respiratory Syncytial Virus Infections
United Kingdom
A Safety And Efficacy Study Of The Combination Of Oral PF-00299804 And Intravenous CP-751,871 Given Every 3 WeeksCompleted
NCT00728390Phase 1Updated Apr 22, 2024
Sponsor: Pfizer
Carcinoma, Non-Small Cell · Neoplasm Metastasis
United States, France, Spain
Bazedoxifene Post Approval Safety Study (PASS) in the European Union (EU)Completed
NCT01416194N/AUpdated Apr 22, 2024
Sponsor: Pfizer
Osteoporosis, Postmenopausal
A Multiple Dose Study of PF-04360365 In Patients With Mild to Moderate Alzheimer's DiseaseCompleted
NCT00945672Phase 2Updated Apr 19, 2024
Sponsor: Pfizer
Alzheimer's Disease
Sweden
Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With CancerCompleted
NCT00942968Phase 4Updated Apr 18, 2024
Sponsor: Pfizer
Cancer
United States, Austria, Canada, Netherlands, Spain
Safety and Immunogenicity of Pneumococcal Conjugate Formulations in Healthy Adults 18 Through 49 Years of AgeCompleted
NCT05489328Phase 1Updated Apr 18, 2024
Sponsor: Pfizer
Pneumococcal Disease
United States
A Study to Evaluate PF-06730512 in Adults With Focal Segmental Glomerulosclerosis (FSGS)Terminated
NCT03448692Phase 2Updated Apr 18, 2024
Sponsor: Pfizer
Focal Segmental Glomerulosclerosis (FSGS)
United States, Canada, Czechia, France, Germany +7 more
Study of PF-07263689 in Participants With Selected Advanced Solid TumorsTerminated
NCT05061537Phase 1Updated Apr 12, 2024
Sponsor: Pfizer
Renal Cell Cancer · Melanoma · Non-Small-Cell Lung Cancer · Hepatocellular Cancer
United States
This is a Retrospective Observational Study Looking at the Characteristics and Outcomes of Participants Taking Inflectra Using the CorEvitas Rheumatoid Arthritis RegistryCompleted
NCT05375942N/AUpdated Apr 12, 2024
Sponsor: Pfizer
Arthritis, Rheumatoid
United States
Comparative Effectiveness Of Tumor Necrosis Factor Inhibitors And Tofacitinib Use In Earlier Lines Of Therapy And Use As Monotherapy.Completed
NCT04721821N/AUpdated Apr 12, 2024
Sponsor: Pfizer
Arthritis Rheumatoid
United States

Previous page Next page